Tuberculosis treatment without rifampin in kidney/kidney–pancreas transplantation: A case series report

Resource type
Journal Article
Title
Tuberculosis treatment without rifampin in kidney/kidney–pancreas transplantation: A case series report
Abstract
Background: The best approach to tuberculosis (TB) treatment in transplanted patients is still unknown. Current guidelines are based on evidence either extrapolated from other populations or observational. Rifampin-containing regimens have strong pharmacokinetic interactions with immunosuppressive regimens, with high rates of organ dysfunction and ∼20% mortality. This report describes the results obtained using non-rifampin-containing regimens to treat confirmed TB in adult patients with kidney/kidney–pancreas transplantation.
Publication
Transplant Infectious Disease
Date
2022-12-14
Journal Abbr
Transplant Infectious Dis
Accessed
12/18/22, 9:02 AM
ISSN
1398-2273, 1399-3062
Short Title
Tuberculosis treatment without rifampin in kidney/kidney–pancreas transplantation
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Radisic, M. V., Pujato, N. R., Bravo, P. M., del Grosso, R. C., Hunter, M., Beltramino, S., Linares González, L., Cornet, M. L., del Carmen Rial, M., Franzini, R. L., Dotta, A. C., León, L. R., Walther, J., Uva, P. D., & Werber, G. (2022). Tuberculosis treatment without rifampin in kidney/kidney–pancreas transplantation: A case series report. Transplant Infectious Disease. https://doi.org/10.1111/tid.13949
Link to this record